Continuous Glucose Monitor (CGM): Clinical Trials

23 trials of Continuous Glucose Monitor (CGM), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 recruiting, 3 withdrawn, 2 active not recruiting. 17 Not applicable, 2 Phase 1, 1 Early Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable17Completed 7, Recruiting 4, Active not recruiting 2, Withdrawn 2, Enrolling by invitation 1, Not yet recruiting 1
Phase 12Completed 1, Withdrawn 1
Early Phase 11Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow Continuous Glucose Monitor (CGM): new trials by email Literature Review of Continuous Glucose Monitor (CGM) trials Research Report on Continuous Glucose Monitor (CGM)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Continuous Glucose Monitor in Hospitalized, Post-operative Patients With Diabetes Mellitus
Continuous Glucose Monitor (CGM) - Diabetes Mellitus
Not applicableWithdrawnMayo Clinic2026-06-012026-07-16
Early Pregnancy Lifestyle and Glucose Patterns: A Substudy of TOFFFY
Continuous glucose monitor (CGM), Wrist actigraphy device, AI-based dietary and meal timing logging mobile application - Continuous Glucose Monitoring, Diabetes, Gestational
Not applicableRecruitingKK Women's and Children's Hospital1402026-05-012026-09-15
Fasting InTervention for Endometrial Cancer
Prolonged Overnight Fasting (POF), Blood Specimen Collection, Blood Sugar Monitor - Endometrial Cancer
Not applicableRecruitingUniversity of Miami422026-02-272026-07-14
Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions
Mediterranean diet (MED), high-fat/low carb diet (HF/LC), and low-fat diet (LF), The integrated sweat sensor and vascular sensor (wearable), continuous glucose monitor (CGM) - NAFLD (Nonalcoholic Fatty Liver Disease)
Not applicableNot yet recruitingVA Greater Los Angeles Healthcare System542025-05-012025-04-17
Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management
MPowerHub, Continuous Glucose Monitor (CGM), Activity Monitor - Type 2 Diabetes Mellitus (T2DM)
Not applicableActive not recruitingAnn-Marie Rosland802025-04-282026-10-29
Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations
Continuous glucose monitor (CGM) - Type 2 Diabetes Mellitus (T2DM)
Not applicableActive not recruitingDiabetes Solutions International402025-03-182026-08-17
Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
Continuous Glucose Monitor (CGM) - Diabetes, Type 2 Diabetes
Not applicableRecruitingYale University172024-11-122025-12-03
A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring
Pharmacist Only, Continuous Glucose Monitor (CGM), Community Health Worker (CHW) - Type 2 Diabetes
Not applicableEnrolling by invitationUniversity of Massachusetts, Worcester3182024-09-272026-09-04
Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)
Nutrition visits, Intensification of diabetes regimen, Continuous glucose monitor (CGM) - Diabetes Mellitus, Type 2
Not applicableRecruitingYale University242024-07-192026-10-09
Assessing Continuous Glucose Monitor Use in Underserved Primary Care Patients
Continuous Glucose Monitor (CGM), Self-monitoring Blood Glucose (SMBG) - Type 2 Diabetes
Not applicableWithdrawnUniversity of Nebraska2023-07-232026-11-12
Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment
Continuous Glucose Monitor (CGM) - Type 2 Diabetes, Mild Cognitive Impairment
Phase 1CompletedNYU Langone Health142023-04-192026-08-27
Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma
Alpelisib, Carboplatin, Hyperpolarized Carbon-13 (13C) Pyruvate - Solid Tumors, Adult, PIK3CA Mutation-Related Tumors
Phase 1WithdrawnPamela Munster2022-11-012022-12-27
CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2))
Continuous Glucose Monitor (CGM) - Diabetes Mellitus, Covid19
Not applicableCompletedMayo Clinic202021-03-032023-08-04
Continuous Glucose Monitoring in Hospitalized Patients With Diabetes Mellitus
Continuous Glucose Monitor (CGM) - Diabetes Mellitus
Not applicableCompletedMayo Clinic1422021-01-012025-07-31
Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes
Insulin, Continuous glucose monitor (CGM) - Cystic Fibrosis-related Diabetes
Phase 4CompletedJagdeesh Ullal132020-09-152025-10-15
Mechanisms for Restoration of Hypoglycemia Awareness
Continuous Glucose Monitor (CGM), Insulin - Type1 Diabetes Mellitus
Early Phase 1CompletedYale University552018-11-072025-02-12
Continuous Glucose Monitoring During and After Surgery
Continuous Glucose Monitor (CGM) - Diabetes
Not applicableCompletedUniversity of Washington102018-08-012023-08-31
CGM Use in Islet Transplant Recipients
Continuous Glucose Monitor (CGM) - Islet Transplantation, Type1 Diabetes Mellitus
Not applicableCompletedUniversity of Virginia72018-02-012020-08-07
CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D)
Continuous Glucose Monitor (CGM) - Type 1 Diabetes Mellitus
Phase 3CompletedJaeb Center for Health Research1532018-01-252026-07-09
Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)
Continuous Glucose Monitor (CGM), Activity Tracker, Coaching - Type2 Diabetes
Not applicableCompletedSavvysherpa, Inc.3582017-09-132021-05-18

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Diabetes Mellitus, Type 2 (7)  ·  Diabetes Mellitus (5)  ·  Diabetes Mellitus, Type 1 (3)  ·  COVID-19 (1)  ·  Cognitive Dysfunction (1)  ·  Diabetes, Gestational (1)  ·  Empowerment (1)  ·  Endometrial Neoplasms (1)  ·  Metabolic Diseases (1)  ·  Neoplasm Metastasis (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Sponsors

Mayo Clinic (3)  ·  Yale University (3)  ·  Savvysherpa, Inc. (2)  ·  Ann-Marie Rosland (1)  ·  Diabetes Solutions International (1)  ·  Jaeb Center for Health Research (1)  ·  Jagdeesh Ullal (1)  ·  KK Women's and Children's Hospital (1)  ·  NYU Langone Health (1)  ·  Nemours Children's Clinic (1)  ·  Pamela Munster (1)  ·  University of Colorado, Denver (1)  ·  University of Massachusetts, Worcester (1)  ·  University of Miami (1)  ·  University of Nebraska (1)

Countries

United States (21)  ·  Singapore (1)

Top investigators

Adrian Dumitrascu, MD (3)  ·  Ann-Marie Rosland, MD, MS (1)  ·  Ben Gerber, MD, MPH (1)  ·  Carissa Low, PhD (1)  ·  David Flum (1)  ·  Drew C Prescott, PharmD (1)  ·  Elizabeth Sanchez Rangel, MD (1)  ·  Irl B Hirsch, MD (1)  ·  Jagdeesh Ullal, MD (1)  ·  Janice Hwang, Hwang (1)  ·  Jenna M Demedis, MD (1)  ·  Kasia Lipska, MD MHS (1)  ·  Larry A Fox, MD (1)  ·  Pamela Munster, MD (1)  ·  See Ling Loy (1)

Results publications

PMID 27435145, PMID 32543683, PMID 37219930, PMID 40229126, PMID 40303270, PMID 42459945

NIH funding

K23DK132517 (1), R01DK020495 (1), R01DK133265 (1), R01DK136788 (1)